• Glancy Prongay & Murray LLP has filed a securities class action in the Southern District of Ohio alleging Bath & Body Works misled investors between June 4, 2024 and November 19, 2025, following sharp year-over-year declines in earnings, multiple guidance cuts, and acknowledgment that recent growth initiatives failed to expand its customer base.
• The lawsuit arrives as Bath & Body Works is both closing more mall locations and refreshing product lines, underscoring the tension between repositioning its business model and addressing concerns about past execution and disclosure.
• We’ll now examine how this lawsuit, and the company’s admitted missteps around promotions and adjacencies, may reshape Bath & Body Works’ investment narrative.

Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit.

Bath & Body Works Investment Narrative Recap

To own Bath & Body Works today, you need to believe the brand can stabilize earnings and rebuild credibility after guidance cuts and softer results, while adapting its store footprint and product assortment. The new securities class action focuses attention on past disclosures, but its direct impact on near term operating performance and key catalyst of improved execution and customer growth appears limited for now; the bigger near term risk remains pressure on margins and guidance if recent changes fail to gain traction.

The most directly connected development is the securities lawsuit, which centers on the period that included sharp earnings declines, lowered guidance and the company’s own admission that promotions and adjacencies did not grow its customer base. This legal overhang now sits alongside management’s shift toward core categories and omni channel initiatives, raising the stakes for how convincingly Bath & Body Works can show that its updated approach is improving underlying demand and restoring investor confidence.

Yet investors should also be aware that if the company’s promotional intensity, customer growth and earnings pressure continue, the gap between expectations and reality could still...

Bath & Body Works' narrative projects $8.1 billion revenue and $860.7 million earnings by 2028. This requires 3.1% yearly revenue growth and about a $132.7 million earnings increase from $728.0 million today.

Uncover how Bath & Body Works' forecasts yield a $24.35 fair value, a 5% upside to its current price.

Exploring Other Perspectives

Ten members of the Simply Wall St Community currently see Bath & Body Works’ fair value between US$24.35 and US$64.56, reflecting a wide span of individual forecasts. Set against concerns about weaker digital performance and guidance cuts, these differing views underline why it can be useful to compare several independent assessments before forming your own expectations for the business.

Explore 10 other fair value estimates on Bath & Body Works - why the stock might be worth just $24.35!

Build Your Own Bath & Body Works Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Bath & Body Works research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Bath & Body Works research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Bath & Body Works' overall financial health at a glance.

No Opportunity In Bath & Body Works?

Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:

• The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
• Outshine the giants: these 24 early-stage AI stocks could fund your retirement.
• Uncover the next big thing with financially sound penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.